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Abstract
Prostate cancer is the second most common cancer in men world-
wide, with approximately 174,650 new cases diagnosed in 2019 in
the U.S. [1]. However, prognosis is relatively good given sufficiently
early detection during the non-metastatic stage, motivating the need
for fast and reliable cancer screening methods. Diffusion weighted
imaging is a magnetic resonance imaging technique that is gaining
traction as a noninvasive method for cancer screening. In 2013, a
new form of diffusion weighted imaging called correlated diffusion
imaging (CDI) was introduced as a potential candidate modality for
building computer-aided clinical decision support systems [2]. We
perform a large scale study, across 101 patient cases with full PI-
RADS score and histopathology, to compare the performance of
correlated diffusion imaging in prostate cancer detection and local-
ization to apparent diffusion coefficient maps, the most commonly
used diffusion weighted imaging-derived imaging modality in can-
cer grading. Using threshold-based classification, experimental re-
sults showed that CDI achieves higher specificity at high sensitivity
values of 90% and 95%, suggesting that CDI is well suited for sce-
narios where high sensitivity is crucial, such as cancer screening.
1 Introduction
A promising imaging modality for diagnosing prostate cancer (PCa)
is apparent diffusion imaging. With the presumed high cellular den-
sity of PCa, the associated tissues should exhibit restricted diffu-
sion characteristics and as such, should have lower apparent dif-
fusion coefficient (ADC) values. While ADC maps shows consider-
able promise in diagnosing PCa [3], delineating between cancerous
tissue and healthy tissue in the prostate gland remains a challenge.
As such, a new imaging modality called correlated diffusion imag-
ing (CDI) and its variant exponential diffusion imaging (eCDI) were
developed to address this issue. While a preliminary study demon-
strated the potential of CDI in computer-aided clinical decision sup-
port systems for detection and localization of PCa, this study was
limited to 20 patients with known PCa [2]. In this study, we investi-
gate the performance of CDI and ADC on a larger scale, with 101
fully-labeled patient cases, 39 with the presence of a cancerous tu-
mour. More specifically, we take a threshold-based classification
approach with the goal of identifying thresholds that achieve high
sensitivities to show the efficacy of CDI and ADC modalities for the
task of diagnosing patients.
2 Method
To assess the potential of CDI in building a diagnostic aid for radiolo-
gists, we focus on leveraging a threshold-based classification strat-
egy. First, full CDI and ADC slices are taken, as shown in images
b) and c) in Figure 1. Second, to identify which region is cancer-
ous, a tumour mask is labeled by radiologists, as shown in Figure
1(a). After cancerous and non-cancerous regions of the whole slice
are identified, a range of threshold values are used to produce a re-
ceiver operating characteristic (ROC) curve to quantitatively assess
the classification of PCa, similar to what was performed in [2]. The
threshold values were chosen based on the minimum and maxi-
mum values of all the prostates in the dataset. The ROC curves
are obtained from the pooled data of all patients. To quantitatively
compare the ROC curves, the area under the curve (AUC) metric is
used.
3 Results and Analysis
As shown in Figure 2, CDI performs significantly better than ADC
when using threshold-based classification for slices. In Table 1,
at high sensitivity, which is desired for scenarios such as cancer
screening, CDI achieves a more balanced tradeoff compare to ADC.
Although CDI achieve higher specificities for both sensitivities, a
Fig. 1: Sample of data used in the study: a) tumour mask, b) corre-
sponding CDI slice and c) ADC slice
Table 1: Threshold-based classification results on all patient cases
Modality AUC Specificity @ 90% sensitivity Specificity @ 95% sensitivity
ADC 0.265 0.154 0.115
CDI 0.933 0.832 0.597
5.5% increase from 90% to 95% in sensitivity results in a 28.2%
decrease in specificity.
Based on the current experimental results, it can be observed
that CDI shows strong promise as an important imaging modality for
building computer-aided clinical decision support systems. For fu-
ture work, we plan to leverage discovery radiomics approaches [4]
to learn better imaging-driven radiomic sequences from ADC and
CDI modalities that can differentiate between healthy and cancer-
ous prostate tissue.
Fig. 2: Receiver operator characteristic (ROC) curves. ROC curves
for all patient cases using both ADC and CDI maps.
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